Please wait while the formulary information is being retrieved.
HYDROQUINONE (HYDROQUINONE MICROSPHERES)
- Dyschromia
- Chloasma
- Obagi Nu-derm Clear Topical Cream
- Obagi Nu-derm Blender Topical Cream
- Obagi Elastiderm Topical Cream
- Hydroquinone Topical Cream
- Hydroquinone Microspheres Er Topical Cream,extended Release
- Blanche Topical Cream
- By Indication
4 % topical cream
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
4 % topical cream
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
4 % topical cream
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
2 % topical cream
- Apply to the affected area(s) by topical route 2 times per day
4 % topical cream
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
microspheres ER 4 % topical cream,extended release
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
4 % topical cream
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
Dyschromia
- Apply to the affected area(s) by topical route 2 times per day in themorning and at bedtime
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Sunburn
Severe
Moderate
- None
HYDROQUINONE (HYDROQUINONE MICROSPHERES)
- Dyschromia
- Chloasma
- None
- None
More Frequent
Severe
Less Severe
- Contact dermatitis
- Hypersensitivity drug reaction
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Dyschromia
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hydroquinone (Topical)
Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Hydroquinone
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Hydroquinone
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Chloasma | |
| H02.71 | Chloasma of eyelid and periocular area |
| H02.711 | Chloasma of right upper eyelid and periocular area |
| H02.712 | Chloasma of right lower eyelid and periocular area |
| H02.713 | Chloasma of right eye, unspecified eyelid and periocular area |
| H02.714 | Chloasma of left upper eyelid and periocular area |
| H02.715 | Chloasma of left lower eyelid and periocular area |
| H02.716 | Chloasma of left eye, unspecified eyelid and periocular area |
| H02.719 | Chloasma of unspecified eye, unspecified eyelid and periocular area |
| L81.1 | Chloasma |
| Dyschromia | |
| L81.9 | Disorder of pigmentation, unspecified |
| 0-9 | A-Z |
|---|---|
| H02.71 | Chloasma of eyelid and periocular area |
| H02.711 | Chloasma of right upper eyelid and periocular area |
| H02.712 | Chloasma of right lower eyelid and periocular area |
| H02.713 | Chloasma of right eye, unspecified eyelid and periocular area |
| H02.714 | Chloasma of left upper eyelid and periocular area |
| H02.715 | Chloasma of left lower eyelid and periocular area |
| H02.716 | Chloasma of left eye, unspecified eyelid and periocular area |
| H02.719 | Chloasma of unspecified eye, unspecified eyelid and periocular area |
| L81.1 | Chloasma |
| L81.9 | Disorder of pigmentation, unspecified |
Formulary Reference Tool